Role of Gut Microbiota in the Pathogenesis of Cardiovascular Diseases and Metabolic Syndrome

被引:1
|
作者
Drapkina, Oxana M. [1 ]
Shirobokikh, Olga E. [1 ]
机构
[1] Natl Med Res Ctr Prevent Med, Petroverigsky Per 10-3, Moscow 101990, Russia
关键词
gut microbiota; obesity; trimethylamine-N-oxide; atherosclerosis; farnesoid X-receptor;
D O I
10.20996/1819-6446-2018-14-4-567-574
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The role of gut microbiota in the pathogenesis of cardiovascular diseases (CVD) and metabolic syndrome has attracted massive attention in the past decade. Accumulating evidence has revealed that the metabolic potential of gut microbiota can be identified as a contributing factor in the development of atherosclerosis, hypertension, heart failure, obesity, diabetes mellitus. The gut-host interaction occurs through many pathways including trimethylamine-N-oxide pathway (TMAO), short-chain fatty acids and second bile acids pathways. TMAO (the hepatic oxidation product of the microbial metabolite of trimethylamine) enhances platelet hyperreactivity and thrombosis risk and predicts major adverse cardiovascular events. Short-chain fatty acids and second bile acids, which are produced with the help of microbiota, can modulate host lipid metabolism as well as carbohydrate metabolism through several receptors such as G-protein-coupled receptors 41,43, farnesoid X-receptor, Takeda-G-protein-receptor-5. This way microbiota can impact host lipid levels, processes of weight gain, insulin sensitivity. Besides these metabolism-dependent pathways, there are some other pathways, which link microbiota and the pathogenesis of CVD. For example, lipopolysaccharide, the major component of the outer bacterial membrane, causes metabolic endotoxemia and low-grade systemic inflammation and contribute this way to obesity and progression of heart failure and atherosclerosis. This review aims to illustrate the complex interplay between microbiota, their metabolites, and the development and progression of CVD and metabolic syndrome. It is also discussed how modulating of gut microbiota composition and function through diet, prebiotics, probiotics and fecal microbiota transplantation can become a novel therapeutic and preventative target for CVD and metabolic syndrome. Many questions remain unresolved in this field and undoubtedly further studies are needed.
引用
收藏
页码:567 / 574
页数:8
相关论文
共 50 条
  • [1] The role and influence of gut microbiota in pathogenesis and management of obesity and metabolic syndrome
    Parekh, Parth J.
    Arusi, Eli
    Vinik, Aaron I.
    Johnson, David A.
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2014, 5
  • [2] Role of gut microbiota in cardiovascular diseases
    Novakovic, Marko
    Rout, Amit
    Kingsley, Thomas
    Kirchoff, Robert
    Singh, Amteshwar
    Verma, Vipin
    Kant, Ravi
    Chaudhary, Rahul
    [J]. WORLD JOURNAL OF CARDIOLOGY, 2020, 12 (04): : 110 - 122
  • [3] The role of gut microbiota in the pathogenesis of rheumatic diseases
    Zhong, Danli
    Wu, Chanyuan
    Zeng, Xiaofeng
    Wang, Qian
    [J]. CLINICAL RHEUMATOLOGY, 2018, 37 (01) : 25 - 34
  • [4] The role of gut microbiota in the pathogenesis of rheumatic diseases
    Danli Zhong
    Chanyuan Wu
    Xiaofeng Zeng
    Qian Wang
    [J]. Clinical Rheumatology, 2018, 37 : 25 - 34
  • [5] Implication of gut microbiota metabolites in cardiovascular and metabolic diseases
    Francois Brial
    Aurélie Le Lay
    Marc-Emmanuel Dumas
    Dominique Gauguier
    [J]. Cellular and Molecular Life Sciences, 2018, 75 : 3977 - 3990
  • [6] Implication of gut microbiota metabolites in cardiovascular and metabolic diseases
    Brial, Francois
    Le Lay, Aurelie
    Dumas, Marc-Emmanuel
    Gauguier, Dominique
    [J]. CELLULAR AND MOLECULAR LIFE SCIENCES, 2018, 75 (21) : 3977 - 3990
  • [7] THE ROLE OF INTESTINAL MICROBIOTA IN THE PATHOGENESIS OF METABOLIC DISEASES
    Wegielska, Iwona
    Suliburska, Joanna
    [J]. ACTA SCIENTIARUM POLONORUM-TECHNOLOGIA ALIMENTARIA, 2016, 15 (02) : 201 - 211
  • [8] The Role of the Gut Microbiota in the Pathogenesis of Antiphospholipid Syndrome
    William E. Ruff
    Silvio M. Vieira
    Martin A. Kriegel
    [J]. Current Rheumatology Reports, 2015, 17
  • [9] The role of the gut microbiota in health and cardiovascular diseases
    Wang, Lu
    Wang, Shiqi
    Zhang, Qing
    He, Chengqi
    Fu, Chenying
    Wei, Quan
    [J]. MOLECULAR BIOMEDICINE, 2022, 3 (01):
  • [10] The role of the gut microbiota in health and cardiovascular diseases
    Lu Wang
    Shiqi Wang
    Qing Zhang
    Chengqi He
    Chenying Fu
    Quan Wei
    [J]. Molecular Biomedicine, 3